# Effect of Tetracaine on Pain Management and Corneal Healing in Patients With Acute Corneal Abrasion

> **NCT02483897** · PHASE3 · WITHDRAWN · sponsor: **Queen's University**

## Conditions studied

- Corneal Abrasion

## Interventions

- **DRUG:** Tetracaine 0.5% ophthalmic drops
- **DRUG:** Normal Saline placebo drops

## Key facts

- **NCT ID:** NCT02483897
- **Lead sponsor:** Queen's University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-06
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** inabililty to recruit at required rate
- **Last updated:** 2018-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02483897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02483897, "Effect of Tetracaine on Pain Management and Corneal Healing in Patients With Acute Corneal Abrasion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02483897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*